Albemarle Corporation – Consensus Indicates Potential 39.7% Upside
Albemarle Corporation found using ticker (ALB) have now 20 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 368 and 135 with the average target price sitting at 274.65. With the stocks previous close at 196.66 this indicates there is a potential upside of 39.7%. The 50 day moving average now sits at 225.76 while the 200 day moving average is 226.01. The company has a market cap of $23,505m. Company Website: https:||www.albemarle.com [stock_market_widget type="chart" template="basic" color="green" assets="ALB" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $32,826m based on the market concensus. Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.
Albemarle Corporation – Consensus Indicates Potential 39.7% Upside
Albemarle Corporation found using ticker (ALB) have now 20 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 368 and 135 with the average target price sitting at 274.65. With the stocks previous close at 196.66 this indicates there is a potential upside of 39.7%. The 50 day moving average now sits at 225.76 while the 200 day moving average is 226.01. The company has a market cap of $23,505m. Company Website: https:||www.albemarle.com [stock_market_widget type="chart" template="basic" color="green" assets="ALB" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $32,826m based on the market concensus. Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.